Guangzhou, China

Xiaoru Zhang

This inventor holds 1 USPTO granted patent. Top assignee: Sun Yat-Senuniversity. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoru Zhang. Retrieved from https://idiyas.com/inventor/xiaoru-zhang-nw44ee84

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Xiaoru Zhang

Introduction

Xiaoru Zhang is a prominent inventor based in Guangzhou, China. She has made significant contributions to the field of biochemistry, particularly in the development of novel compounds that have therapeutic potential. Her work is characterized by a strong focus on inhibitors that target specific enzymes involved in DNA processing.

Latest Patents

Xiaoru Zhang holds a patent for "OXYNITIDINE DERIVATIVES USEFUL AS INHIBITORS OF TOPOISOMERASE IB (TOP1) AND TYROSYL-DNA PHOSPHODIESTERASE 1 (TDP1)." This innovative patent highlights her expertise in creating compounds that can potentially lead to advancements in cancer treatment and other diseases related to DNA damage.

Career Highlights

Zhang is affiliated with Sun Yat-sen University, where she conducts her research and collaborates with other scientists. Her academic background and research endeavors have positioned her as a key figure in her field. With 1 patent to her name, she continues to push the boundaries of scientific discovery.

Collaborations

Throughout her career, Xiaoru Zhang has worked alongside notable colleagues, including Lin-Kun An and Haowen Wang. These collaborations have enriched her research and contributed to the advancement of their shared scientific goals.

Conclusion

Xiaoru Zhang's innovative work and dedication to her field exemplify the spirit of scientific inquiry. Her contributions, particularly in the area of DNA enzyme inhibitors, hold promise for future medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…